Lawrence Young

51 - 60 out of 149Page size: 10

Publications

  1. 2002
  2. Published

    TRAF1 is a critical regulator of JNK signalling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 (LMP1) but not CD40

    Aris Eliopoulos, Sarah Blake, Clare Davies, Paul Murray & Lawrence Young, 20 Dec 2002, In: Journal of virology. 77, 2, p. 1316-1328 13 p.

    Research output: Contribution to journal › Article

  3. 2003
  4. Published

    BCL2 expression predicts survival in patients receiving synchronous chemoradiotherapy in advanced transitional cell carcinoma of the bladder

    Syed Hussain, Louise Hiller, Paul Murray, Lawrence Young & Nicholas James, 1 Jan 2003, In: Oncology reports. 10, p. 571-576 6 p.

    Research output: Contribution to journal › Article

  5. Published

    Dendritic cell vaccination for hepatocellular carcinoma

    Daniel Palmer, Nazzia Mirza, Jane Steele, Neil Steven, Lawrence Young, David Adams, 1 Jan 2003, p. 280A.

    Research output: Contribution to conference (unpublished) › Abstract

  6. Published

    Inhibition of metalloproteinase cleavage enhances the cytotoxicity of Fas ligand

    Anne Milner, Nicky Green, Aris Eliopoulos & Lawrence Young, 1 Jan 2003, In: Journal of Immunology. 170, p. 677-685 9 p.

    Research output: Contribution to journal › Article

  7. Published

    Reactivity with a monoclonal antibody to Epstein-Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome

    Paul Murray, Andrew Bell, Judith Timms, David Rowlands, Christopher McConkey & Lawrence Young, 1 Jan 2003, In: Cancer Research. 63, p. 2338-2343 6 p.

    Research output: Contribution to journal › Article

  8. Published

    Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia

    Stuart Collins, Heather Winter & Lawrence Young, 4 Jan 2003, In: Lancet. 361, 9351, p. 40-43 4 p.

    Research output: Contribution to journal › Article

  9. Published

    Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling

    Christopher Dawson, Aris Eliopoulos & Lawrence Young, 31 Jan 2003, In: Journal of Biological Chemistry. 278, 6, p. 3694-3704 11 p.

    Research output: Contribution to journal › Article

  10. Published

    The effect of Epstein-Barr virus status on survival in age and sex defined subgroups of patients with advanced Hodgkin's disease

    Lucinda Billingham, Joanne Gough, Lawrence Young & Paul Murray, 1 Feb 2003, In: Annals of Oncology. 14, 2, p. 282-290 9 p.

    Research output: Contribution to journal › Article

  11. Published

    Absence of Epstein-Barr virus DNA in the tumour cells of European hepatocellular carcinoma

    Andrew Bell, Judith Timms, Stefan Hubscher, Lawrence Young & Paul Murray, 15 Feb 2003, In: Virology. 306, 2, p. 236-243 8 p.

    Research output: Contribution to journal › Article

  12. Published

    Pro-apoptotic genes BAX and CD40L are predictors of survival in transitional cell carcinoma of the bladder

    Syed Hussain, Louise Hiller, Paul Murray, Lawrence Young & Nicholas James, 24 Feb 2003, In: British Journal of Cancer. 88, 4, p. 586-592 7 p.

    Research output: Contribution to journal › Article

Previous 12 3 4 5 6 7 8 9 ...15 Next